Changes in NK Cell Subsets and Receptor Expressions in HIV-1 Infected Chronic Patients and HIV Controllers

• Published in: Frontiers in immunology Vol. 12; p. 792775
• Main Authors: Zhang, Zhi, Zhou, Ying, Lu, Jing, Chen, Yuan-Fang, Hu, Hai-Yang, Xu, Xiao-Qin, Fu, Geng-Feng
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 16.12.2021
• Subjects: Adolescent; Adult; Case-Control Studies; Child; Chronic Disease; Cytokines - blood; Female; HIV controller; HIV Infections - blood; HIV Infections - diagnosis; HIV Infections - immunology; HIV Infections - virology; HIV Non-Progressors; HIV-1 - immunology; HIV-1 - pathogenicity; Host-Pathogen Interactions; Humans; Immunity, Innate; Immunology; Killer Cells, Natural - immunology; Killer Cells, Natural - metabolism; Killer Cells, Natural - virology; Lectins, C-Type - blood; Male; Middle Aged; Natural Cytotoxicity Triggering Receptor 1 - blood; NK cell; NK Cell Lectin-Like Receptor Subfamily K - blood; NK cell subset; Phenotype; plasma cytokine; receptors of NK cell; Receptors, Natural Killer Cell - blood; Young Adult; HIV controller; NK cell subset; NK cell; receptors of NK cell; plasma cytokine
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2021.792775

Natural killer (NK) cells are major effectors of the innate immune response and purported to play an influential role in the spontaneous control of HIV infection. In the present study, we compared the phenotypes of NK cells in the peripheral blood of three groups of subjects with chronic HIV-1 infection, HIV controllers, and healthy donors. The results showed that CD56 /CD16 NK cell subsets decreased in chronic patients and remained unchanged in controllers. Notably, we found that people living with chronic HIV-1 infection had suppressed NKp80, NKp46, and NKG2D expressions on NK cells compared to healthy donors, while HIV controllers remained unchanged. In contrast, NKG2D expression was substantially higher in controllers than in chronic patients (M=97.67, p<0.001). There were no significant differences in inhibitory receptors KIR3DL1 and KIR2DL1 expressions. In addition, plasma cytokine IFN-γ, TNF-α and IL-12showed higher levels in HIV controllers compared to chronic patients. Overall, our study revealed that, as compared to chronic patients, HIV controllers show an increased activating receptors expression and higher number ofCD56 /CD16 NK cell subset, with increased expression levels of plasma cytokines, suggesting that higher immune activation in controllers may have a key role in killing and suppressing HIV.